良性阵发性位置性眩晕复位后残余头晕的研究进展

李溪, 陈钢钢, 曾玮, 等. 良性阵发性位置性眩晕复位后残余头晕的研究进展[J]. 临床耳鼻咽喉头颈外科杂志, 2022, 36(3): 228-232. doi: 10.13201/j.issn.2096-7993.2022.03.015
引用本文: 李溪, 陈钢钢, 曾玮, 等. 良性阵发性位置性眩晕复位后残余头晕的研究进展[J]. 临床耳鼻咽喉头颈外科杂志, 2022, 36(3): 228-232. doi: 10.13201/j.issn.2096-7993.2022.03.015
LI Xi, CHEN Ganggang, ZENG Wei, et al. The research progress of residual dizziness after reduction of benign paroxysmal positional vertigo[J]. J Clin Otorhinolaryngol Head Neck Surg, 2022, 36(3): 228-232. doi: 10.13201/j.issn.2096-7993.2022.03.015
Citation: LI Xi, CHEN Ganggang, ZENG Wei, et al. The research progress of residual dizziness after reduction of benign paroxysmal positional vertigo[J]. J Clin Otorhinolaryngol Head Neck Surg, 2022, 36(3): 228-232. doi: 10.13201/j.issn.2096-7993.2022.03.015

良性阵发性位置性眩晕复位后残余头晕的研究进展

  • 基金项目:
    2020年山西省医学重点科研项目(No:2020XM13)
详细信息

The research progress of residual dizziness after reduction of benign paroxysmal positional vertigo

More Information
  • 加载中
  • [1]

    Giommetti G, Lapenna R, Panichi R, et al. Residual Dizziness after Successful Repositioning Maneuver for Idiopathic Benign Paroxysmal Positional Vertigo: A Review[J]. Audiol Res, 2017, 7(1): 178. doi: 10.4081/audiores.2017.178

    [2]

    Di Girolamo S, Ottaviani F, Scarano E, et al. Postural control in horizontal benign paroxysmal positional vertigo[J]. Eur Arch Otorhinolaryngol, 2000, 257(7): 372-375. doi: 10.1007/s004050000243

    [3]

    Inagaki T, Suzuki M, Otsuka K, et al. Model experiments of BPPV using isolated utricle and posterior semicircular canal[J]. Auris Nasus Larynx, 2006, 33(2): 129-134. doi: 10.1016/j.anl.2005.09.001

    [4]

    Faralli M, Lapenna R, Giommetti G, et al. Residual dizziness after the first BPPV episode: role of otolithic function and of a delayed diagnosis[J]. Eur Arch Otorhinolaryngol, 2016, 273(10): 3157-3165. doi: 10.1007/s00405-016-3947-z

    [5]

    Martellucci S, Pagliuca G, de Vincentiis M, et al. Features of Residual Dizziness after Canalith Repositioning Procedures for Benign Paroxysmal Positional Vertigo[J]. Otolaryngol Head Neck Surg, 2016, 154(4): 693-701. doi: 10.1177/0194599815627624

    [6]

    Seo T, Shiraishi K, Kobayashi T, et al. Residual dizziness after successful treatment of idiopathic benign paroxysmal positional vertigo originates from persistent utricular dysfunction[J]. Acta Otolaryngol, 2017, 137(11): 1149-1152. doi: 10.1080/00016489.2017.1347824

    [7]

    Oh KH, Suh KD, Lee YH, et al. Clinical utility of cervical vestibular-evoked myogenic potentials in predicting residual dizziness after benign paroxysmal positional vertigo[J]. Clin Neurophysiol, 2019, 130(1): 95-100. doi: 10.1016/j.clinph.2018.11.005

    [8]

    黄爱萍, 顾东胜, 冯爱凤, 等. 良性阵发性位置性眩晕残余症状的影响因素及oVEMP分析[J]. 浙江医学, 2020, 42(23): 2511-2515. doi: 10.12056/j.issn.1006-2785.2020.42.23.2020-2945

    [9]

    Wu P, Yang J, Huang X, et al. Predictors of residual dizziness in patients with benign paroxysmal positional vertigo after successful repositioning: A multi-center prospective cohort study[J]. J Vestib Res, 2021, 31(2): 119-129. doi: 10.3233/VES-201535

    [10]

    田永胜, 张彦, 马荣, 等. 管石复位治疗后出现残余症状的良性阵发性位置性眩晕患者VEMP特点[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(11): 845-849. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201811013.htm

    [11]

    Kim HA, Lee H. Autonomic dysfunction as a possible cause of residual dizziness after successful treatment in benign paroxysmal positional vertigo[J]. Clin Neurophysiol, 2014, 125(3): 608-614. doi: 10.1016/j.clinph.2013.08.008

    [12]

    钱淑霞, 张晓玲, 官俏兵. 良性阵发性位置性眩晕患者残余头晕的皮肤交感反应研究[J]. 中国耳鼻咽喉头颈外科, 2016, 23(9): 546-548. https://www.cnki.com.cn/Article/CJFDTOTAL-EBYT201609016.htm

    [13]

    Pollak L, Davies RA, Luxon LL. Effectiveness of the particle repositioning maneuver in benign paroxysmal positional vertigo with and without additional vestibular pathology[J]. Otol Neurotol, 2002, 23(1): 79-83. doi: 10.1097/00129492-200201000-00018

    [14]

    胡进, 傅伟达, 尤克, 等. 继发性和原发性良性发作性位置性眩晕残余头晕症状的比较[J]. 中华全科医学, 2017, 15(10): 1694-1696. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201710019.htm

    [15]

    Sato G, Sekine K, Matsuda K, et al. Risk factors for poor outcome of a single Epley maneuver and residual positional vertigo in patients with benign paroxysmal positional vertigo[J]. Acta Otolaryngol, 2013, 133(11): 1124-1127. doi: 10.3109/00016489.2013.817681

    [16]

    Teggi R, Quaglieri S, Gatti O, et al. Residual dizziness after successful repositioning maneuvers for idiopathic benign paroxysmal positional vertigo[J]. ORL J Otorhinolaryngol Relat Spec, 2013, 75(2): 74-81. doi: 10.1159/000350255

    [17]

    Ding L, Lin T, Zhou X, et al. Analysis of related factors of recurrence in horizontal semicircular canal benign paroxysmal positional vertigo: a pilot study[J]. Acta Otolaryngol, 2020, 140(1): 8-13. doi: 10.1080/00016489.2019.1685129

    [18]

    谷李欣, 陈建勇, 张勤, 等. 后半规管良性阵发性位置性眩晕病程对复位成功后残余症状的影响[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(11): 976-980. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202111004.htm

    [19]

    张姝, 徐凌, 高伟, 等. 良性阵发性位置性眩晕手法复位后残余症状的相关因素分析[J]. 听力学及言语疾病杂志, 2019, 27(4): 364-369. doi: 10.3969/j.issn.1006-7299.2019.04.005

    [20]

    Teggi R, Giordano L, Bondi S, et al. Residual dizziness after successful repositioning maneuvers for idiopathic benign paroxysmal positional vertigo in the elderly[J]. Eur Arch Otorhinolaryngol, 2011, 268(4): 507-511. doi: 10.1007/s00405-010-1422-9

    [21]

    Wang LY, Peng H, Huang WN, et al. [Application of the dizziness handicap inventory in the patients with benign paroxysmal positional vertigo][J]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2016, 30(8): 595-597.

    [22]

    Sim E, Tan D, Hill K. Poor Treatment Outcomes Following Repositioning Maneuvers in Younger and Older Adults With Benign Paroxysmal Positional Vertigo: A Systematic Review and Meta-analysis[J]. J Am Med Dir Assoc, 2019, 20(2): 224. e1-224. e23. doi: 10.1016/j.jamda.2018.11.019

    [23]

    孙勍, 张清华, 彭新, 等. 防跌倒临床策略[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(2): 108-111. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202102005.htm

    [24]

    D'Silva LJ, Staecker H, Lin J, et al. Retrospective data suggests that the higher prevalence of benign paroxysmal positional vertigo in individuals with type 2 diabetes is mediated by hypertension[J]. J Vestib Res, 2016, 25(5/6): 233-239.

    [25]

    Jiang X, He L, Gai Y, et al. Risk factors for residual dizziness in patients successfully treated for unilateral benign posterior semicircular canal paroxysmal positional vertigo[J]. J Int Med Res, 2020, 48(12): 300060520973093.

    [26]

    Pal'chun VT, Guseva AL, Olimpieva SP. [Clinical features and treatment of multi-canal benign paroxysmal positional vertigo][J]. Vestn Otorinolaringol, 2019, 84(6): 28-32. doi: 10.17116/otorino20198406128

    [27]

    Guneri EA, Kustutan O. The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo[J]. Otolaryngol Head Neck Surg, 2012, 146(1): 104-108. doi: 10.1177/0194599811419093

    [28]

    Deng W, Yang C, Xiong M, et al. Danhong enhances recovery from residual dizziness after successful repositioning treatment in patients with benign paroxysmal positional vertigo[J]. Am J Otolaryngol, 2014, 35(6): 753-757. doi: 10.1016/j.amjoto.2014.07.001

    [29]

    姚琦, 潘晓峰, 潘宋斌, 等. 金纳多治疗良性阵发性位置性眩晕复位成功后残余头晕症状的疗效评估[J]. 中华耳科学杂志, 2020, 18(5): 897-901. doi: 10.3969/j.issn.1672-2922.2020.05.017

    [30]

    Acar B, Karasen RM, Buran Y. Efficacy of medical therapy in the prevention of residual dizziness after successful repositioning maneuvers for Benign Paroxysmal Positional Vertigo(BPPV)[J]. B-ENT, 2015, 11(2): 117-121.

    [31]

    Jalali MM, Gerami H, Saberi A, et al. The Impact of Betahistine versus Dimenhydrinate in the Resolution of Residual Dizziness in Patients with Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial[J]. Ann Otol Rhinol Laryngol, 2020, 129(5): 434-440. doi: 10.1177/0003489419892285

    [32]

    Jung HJ, Koo JW, Kim CS, et al. Anxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigo[J]. Acta Otolaryngol, 2012, 132(3): 277-284. doi: 10.3109/00016489.2011.637179

    [33]

    胡进, 许俊杰, 傅伟达. 氟哌噻吨美利曲辛片治疗继发性BPPV老年患者残余头晕症状的疗效观察[J]. 中国现代应用药学, 2018, 35(6): 888-890. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYD201806022.htm

    [34]

    王霞, 田彦静, 单静. 心理干预联合手法复位对老年人良性阵发性位置性眩晕的疗效分析[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(4): 264-269. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201804006.htm

    [35]

    Kim MB, Lee HS, Ban JH. Vestibular suppressants after canalith repositioning in benign paroxysmal positional vertigo[J]. Laryngoscope, 2014, 124(10): 2400-2403. doi: 10.1002/lary.24741

    [36]

    Wu P, Cao W, Hu Y, et al. Effects of vestibular rehabilitation, with or without betahistine, on managing residual dizziness after successful repositioning manoeuvres in patients with benign paroxysmal positional vertigo: a protocol for a randomised controlled trial[J]. BMJ Open, 2019, 9(6): e026711. doi: 10.1136/bmjopen-2018-026711

    [37]

    Duan Z, Fu C, Tang T, et al. Social support reduces residual dizziness after canalith repositioning procedure in benign paroxysmal positional vertigo. Biomedical Research(India), 2018, 29(10): 1988-1993.

    [38]

    Casani AP, Navari E, Albera R, et al. Approach to residual dizziness after successfully treated benign paroxysmal positional vertigo: effect of a polyphenol compound supplementation[J]. Clin Pharmacol, 2019, 11: 117-125.

  • 加载中
计量
  • 文章访问数:  1931
  • PDF下载数:  964
  • 施引文献:  0
出版历程
收稿日期:  2021-05-10
修回日期:  2021-11-08
刊出日期:  2022-03-03

目录